APSR2026-38

 
Late-Breaking
Submitted
Poster Presentation
 
AP02-002
P10
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1199810-46904-APSR26_Poster Template_411644ver1.3_431218.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
8

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Kohei Fujita * NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan
Shogo Toyama - NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan
Takanori Ito - NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan
Takuma Imakita - NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan
Issei Oi - NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan
Osamu Kanai - NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan NHO Kyoto Medical Center Infectious Diseases Kyoto Japan
Yuki Yamamoto - NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan
Kiminobu Tanizawa - NHO Kyoto Medical Center Respiratory Medicine Kyoto Japan
 
 
 
 
 
 
 
Presenting Author Details
Kohei
Fujita
kfujita.acd@gmail.com
+819095017429
41-50
Japan
Original Research
A Single-Centre Analysis of the Clinical Characteristics of Nontuberculous Mycobacterial Lung Disease Caused by Rare Species
Maximum 25 words
Abstract Content
In clinical practice, nontuberculous mycobacterial (NTM) lung disease caused by rare species is occasionally encountered; however, its clinical significance remains unclear.
Among NTM isolates identified at NHO Kyoto Medical Centre between January 2015 and December 2025, species other than Mycobacterium avium, M. intracellulare, M. abscessus, and M. kansasii were defined as rare species. We retrospectively identified and analysed patients with NTM lung disease caused by these rare species.
Seventeen rare NTM species were detected in 45 patients. The mean age was 75.2 years, with male predominance (60%). The five most frequently detected NTM species were M. gordonae (8 cases), M. lentiflavum (8), M. fortuitum (7), M. mageritense (4), and M. paragordonae (4). Of the 45 patients, 17 (37.8%) met the ATS/ERS diagnostic criteria. Diagnosis was established by sputum culture (≥2 positive samples) in 11 cases and by bronchoalveolar lavage in 6 cases. Among diagnosed patients, radiological patterns included nodular bronchiectatic type in 13 cases, fibrocavitary type in 2 cases, and unclassifiable patterns in 2 cases. The most common comorbidities were malignancy (29.4%) and chronic obstructive pulmonary disease (COPD) (23.5%). Treatment was initiated in 5 cases, whilst the remaining 12 cases were managed with observation alone. Reasons for observation without treatment included patient refusal (7 cases), uncertainty regarding optimal treatment regimens (2 cases), and the presence of other severe comorbidities (3 cases). Clinical outcomes included improvement in 2 cases, stability in 6 cases, and progression in 9 cases. Seven of the 12 (58.3%) untreated patients experienced disease progression.
The majority of patients with NTM lung disease caused by rare species did not meet diagnostic criteria and were considered to have colonisation. Even among cases meeting the diagnostic criteria, most were managed through observation without treatment. Approximately half of the untreated patients exhibited gradual disease progression, suggesting potential benefit from therapeutic intervention. However, the lack of established treatment regimens remains a significant challenge.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
nontuberculous mycobacteria, rare NTM species, rare NTM lung diseases
maximum 3 keywords and no abbreviations, separated by commas
We have no conflict of interest to declare.
317